Answers are grounded in this paper and cite their sources.
In 1998, about 30 new medicinal chemical entities in the field of antibacterials and antifungals were presented during the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, held in San Diego. Among these compounds, only a few of them seem to be candidates for preclinical and clinical development: GAR 936, RWJ 54,418, ME 1209, L-084, FK 483, and DC 756. Other compounds seem to be in the preselection stage or potential lead compounds.
No takes yet. Share an insight, caveat, or question.
A. Bryskier (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: